The Alzheimer’s disease drug candidate J147 decreases blood plasma fatty acid levels via modulation of AMPK/ACC1 signaling in the liver
Author: D Kepchia, L Huang, A Currais, Z Liang, et al.
Year Published: 2022
Media Outlet: Biomedicine & Pharmacotherapy
Open Access? Yes
Matrix: Plasma and Serum
Biological Themes: Liver function
Product(s): Global Discovery Panel
Cited in over 3,000 publications, we help scientists and manufacturers gain greater insight into their studies through metabolomics.
GET STARTED
Talk with an expert
Request a quote, get detailed information on sample types, or learn how metabolomics can accelerate your research. Find our contact details are here.
Find us on:
